Pulmonology clinical trials recruiting in Pennsylvania

84 recruiting pulmonology trials match in Pennsylvania. Showing 20.

• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Recruiting

  Phase 2 · Cumberland Pharmaceuticals · Philadelphia, Pennsylvania

• Multi-Center Clean Air Randomized Controlled Trial in COPDRecruiting

  Phase 3 · JHSPH Center for Clinical Trials · West Reading, Pennsylvania

• Feasibility of Semaglutide in Advanced Lung DiseaseRecruiting

  Phase 1 / Phase 2 · University of Pennsylvania · Philadelphia, Pennsylvania

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Recruiting

  Phase 3 · AstraZeneca · Cullman, Alabama

• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)Recruiting

  N/A · Jaeb Center for Health Research · Philadelphia, Pennsylvania

• Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS RegistryRecruiting

  N/A · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Philadelphia, Pennsylvania

• SMART Implementation-Effectiveness Trial 1Recruiting

  N/A · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania

• Supporting Evidence-based Responses to Emotional Needs in EmphysemaRecruiting

  N/A · University of Pennsylvania · Philadelphia, Pennsylvania

• A Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsRecruiting

  N/A · Nicole Hamblett · Hershey, Pennsylvania

• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of TreatmentRecruiting

  Phase 2 · Expedition Therapeutics, Inc · Philadelphia, Pennsylvania

• SPIROMICS Study of Early COPD Progression (SOURCE)Recruiting

  N/A · University of Massachusetts, Worcester · Philadelphia, Pennsylvania

• A Study of CDX-622 in Participants With Mild to Moderate AsthmaRecruiting

  Phase 1 · Celldex Therapeutics · Pittsburgh, Pennsylvania

• A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFRecruiting

  Phase 2 · ReCode Therapeutics · Pittsburgh, Pennsylvania

• Effect of Ensifentrine on Sputum Markers of Inflammation in COPDRecruiting

  Phase 2 · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA · Pittsburgh, Pennsylvania

• Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyRecruiting

  Phase 3 · GlaxoSmithKline · DuBois, Pennsylvania

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)Recruiting

  Phase 3 · AstraZeneca · DuBois, Pennsylvania

• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDRecruiting

  N/A · Nuvaira, Inc. · DuBois, Pennsylvania

• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin ProteinRecruiting

  Phase 3 · Takeda · Hershey, Pennsylvania

• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruiting

  Phase 2 / Phase 3 · Pfizer · DuBois, Pennsylvania

• Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDRecruiting

  Phase 2 · Altesa Biosciences, Inc. · DuBois, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.